← SynDRA
RICOLINOSTAT
SynDRA canonical compound SYN0037193 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | HDAC6 |
|---|
| Mechanism of action | HDAC inhibitor |
|---|
All known targets
- HDAC6
- HDAC1
- HDAC2
- HDAC3
- HDAC8
Mechanisms of action (all sources)
- histone deacetylase inhibitor
- HDAC6 INHIBITOR
- Histone deacetylase 6 inhibitor
- HDAC1 INHIBITOR
- HDAC2 INHIBITOR
- HDAC3 INHIBITOR
- HDAC8 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABL1
- AURKA
- SIRT2
- SIRT1
- PSMB5
- PIK3CD
- MAPK1
- LTA4H
- KDM1A
- HDAC9
- HDAC7
- HDAC5
- HDAC4
- HDAC11
- HDAC10
- GSK3B
- FGFR2
- CSNK1D
- CDK2
- BRPF1
- BRD4
- TRIM24
Cross-references
Synonyms
- ACY-1215
- ACY-63
- Rocilinostat
- Rocilinostat (ACY-1215)
- 2-(Diphenylamino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide
- UNII-WKT909C62B
- WKT909C62B
- 2-(Diphenylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]-5-pyrimidinecarboxamide
- AK151416
- N-[7-(hydroxyamino)-7-oxoheptyl]-2-(N-phenylanilino)pyrimidine-5-carboxamide
- 2-(diphenylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]pyrimidine-5-carboxamide
- Ricolinostat [USAN:INN]
- AH4
- Ricolinostat (USAN/INN)
- MLS006011181
- SCHEMBL574580
- GTPL7010
- ACY 1215
- ricolinostatum
- RefChem:883628
- DTXCID0079639
- Histone Deacetylase 6 InhibitorACY-1215
- MFCD22666356
- Ricolinostat (ACY-1215)
- Ricolinostat [USAN]
- RICOLINOSTAT [INN]
- RICOLINOSTAT [WHO-DD]
- Ricolinostat (ACY-1215)?
- orb1305408
- CHEBI:95073
- EX-A139
- GLXC-90379
- HMS3426C09
- HMS3653F17
- HMS3886L21
- BDBM50439674
- NSC767952
- s8001
- ACY 1215; ACY 63;
Look up RICOLINOSTAT in the interactive SynDRA portal →